Montreal, May 10, 2001
Andre De Villers, M.D., President and CEO of Theratechnologies Inc. present his report at the company annual meeting, May 10 in Montreal, CANADA.
Theratechnologies Inc is a Canadian biopharmaceutical company engaged in the fields of therapeuticc peptides and cell theraphy.
One of their products ; Theralux (tm) has reached Phase I/II status in CML ans is at a pivotal stage in NHL, bringing this product closer to commercialization
By the 2nd quater...
You must be logged in to leave comments. Click here to log in.